Literature DB >> 8913849

Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: physical selection.

Y Hong1, T V Chirila, M J Cuypers, I J Constable.   

Abstract

More than 300 polymers of 1-vinyl-2-pyrrolidinone (VP) were synthesized, subjected to hydration, and characterized with the aim to select the most suitable materials as potential artificial substitutes for the vitreous body of the eye. The materials include cross-linked homopolymers, uncross-linked copolymers of VP with 2-hydroxyethyl methacrylate (HEMA), and cross-linked copolymers VP/HEMA. Five different cross-linking agents, both hydrophobic and hydrophilic, were used in this study. The resulting hydrogels, with equilibrium water contents ranging between 66.5 and 99.1%, were first subjected to a selection based on their physical behavior during manipulation, after which only the transparent, viscoelastic gels were further considered. Subsequent injectability and visual acuity tests, as well as the evaluation of light transmission characteristics, reduced further the number of potential candidates for vitreous substitution to only thirteen hydrogels. An eliminatory strategy based on physical properties of the potential vitreous substitutes is essential in order to avoid unnecessary sacrifice of experimental animals for in vivo assessment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913849     DOI: 10.1177/088532829601100202

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  2 in total

Review 1.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.

Authors:  Traian V Chirila; Piroska E Rakoczy; Kerryn L Garrett; Xia Lou; Ian J Constable
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

Review 2.  Vitreous substitutes: the present and the future.

Authors:  Simone Donati; Simona Maria Caprani; Giulia Airaghi; Riccardo Vinciguerra; Luigi Bartalena; Francesco Testa; Cesare Mariotti; Giovanni Porta; Francesca Simonelli; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.